A Study of Mirikizumab (LY3074828) in Participants With Moderate to Severe Plaque Psoriasis

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2016
The main purpose of this study is to evaluate the efficacy of the study drug mirikizumab in participants with moderate to severe plaque psoriasis.
Epistemonikos ID: ec4d3b10723cc0e54af04119ccc3d11442e43c73
First added on: May 17, 2024